US Stock MarketDetailed Quotes
ZVRA Zevra Therapeutics
- 9.650
- +0.160+1.69%
Trading Nov 26 11:36 ET
515.08MMarket Cap-4530P/E (TTM)
9.740High9.333Low111.00KVolume9.560Open9.490Pre Close1.07MTurnover0.26%Turnover RatioLossP/E (Static)53.38MShares9.76052wk High7.38P/B415.72MFloat Cap4.20052wk Low--Dividend TTM43.08MShs Float418.400Historical High--Div YieldTTM4.29%Amplitude2.560Historical Low9.623Avg Price1Lot Size
About Zevra Therapeutics Company
Zevra Therapeutics, Inc. is a commercial-stage rare disease company that combines science, data and patient needs to create therapies for diseases with limited or no treatment options. The firm focuses on the treatment of rare neurological and sleep conditions such as certain Urea Cycle Disorders, Niemann Pick Disease Type C and Idiopathic Hypersomnia. The company receives royalties for AZSTARYS from its commercial partner Corium. The company was founded by Christal M. M. Mickle and Travis C. Mickle on October 30, 2006 and is headquartered in Celebration, FL.
Company Profile
SymbolZVRA
Company NameZevra Therapeutics
Listing DateApr 16, 2015
Founded2006
CEOMr. Neil F. McFarlane, M.S.
MarketNASDAQ
Employees69
Fiscal Year Ends12-31
Address1180 Celebration Boulevard,Suite 103
CityCelebration
ProvinceFlorida
CountryUnited States of America
Zip Code34747
Phone1-321-939-3416
Websitehttp://zevra.com
Company Executives
- Name
- Position
- Salary
- Neil F. McFarlane, M.S.
- Director, President and Chief Executive Officer
- 3.45M
- R. LaDuane Clifton, C.P.A.,M.B.A.
- Chief Financial Officer, Secretary and Treasurer
- 2.26M
- Joshua Schafer, M.B.A.
- Chief Commercial Officer and Executive Vice President, Business Development
- 1.82M
- Christal M M. Mickle, M.A.
- Chief Development Officer
- 1.67M
- Dr. Adrian Quartel, M.D.
- Chief Medical Officer
- --
- Dr. Sven Guenther, PhD
- Chief Scientific Officer
- --
- Timothy J. Sangiovanni
- Senior Vice President, Corporate Controller and Principal Accounting Officer
- --
- Tamara A. Favorito
- Chairman of the Board
- 324.39K
- Dr. Alvin Shih, M.D.
- Director
- --
- Douglas W. Calder
- Independent Director
- 258.02K
- Thomas Anderson
- Independent Director
- 243.04K
- John B. Bode
- Independent Director
- 264.31K
- Corey Watton
- Independent Director
- 260.67K
- Dr. Wendy L. Dixon, PhD
- Independent Director
- 274.00K
Analysis
Price Target
No Data
Heat List
US
Overall
Symbol
Latest Price
% Chg
No Data